Physician

Alfred P Vargas, MD

According to 2025 Medicare claims, Alfred Vargas, MD (NPI: 1144406687) practices hematology/oncology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OHIOHEALTH CORPORATION (NPI: 1578545273; TIN: 311351965) and primary practice location at 43147-9653.

Vargas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 284 traditional Medicare patients, billed 669 HCPCS/CPT codes, and received $49,325 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 604 prescription claims across 134 beneficiaries totaling $1,746,430 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 46 claims. Open Payments data shows 7 records totaling $153. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $916,462 to $49,325. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $879,959 and ending at $1,746,430. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,716 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	460	61,452	$916,462
2016	540	68,055	$984,234
2017	554	65,761	$1,016,768
2018	462	54,159	$891,772
2019	143	439	$38,384
2020	158	485	$40,045
2021	220	651	$60,046
2022	230	626	$54,210
2023	271	616	$52,363
2024	284	669	$49,325

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	142	661	$879,959
2016	138	590	$740,547
2017	118	523	$1,043,093
2018	117	456	$829,102
2019	52	133	$316,431
2020	62	252	$211,997
2021	81	424	$760,957
2022	86	456	$1,027,786
2023	112	487	$1,564,217
2024	134	604	$1,746,430

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	150	$79,866
2016	11	78	$36,900
2017	N/R	54	$15,778
2018	N/R	32	$5,933
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	29	$3,072
2022	N/R	52	$2,369
2023	N/R	46	$12,865
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	45	48	$102
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	52	52	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	101	165	$81
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	35	42	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	184	278	$54

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	23	644	$365,419
Nubeqa	Darolutamide	13	390	$182,110
Tagrisso	Osimertinib Mesylate	12	360	$179,457
Lenalidomide	Lenalidomide	12	336	$160,721
Abiraterone Acetate	Abiraterone Acetate	46	1,380	$118,700

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$153	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alfred P. Vargas, MD?

Tedicare shows public-source Medicare data for Alfred P. Vargas, MD (NPI 1144406687), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alfred P. Vargas, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alfred P. Vargas, MD?

Alfred P. Vargas, MD is linked to OHIOHEALTH CORPORATION (billing NPI 1578545273) in the available physician profile data.

Does Alfred P. Vargas, MD have Open Payments data?

Alfred P. Vargas, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.